Pharmaceutical Executive-04-01-2013

Pharmaceutical Executive
Country Report

April 01, 2013

Belgium is a hub for clinical trials, a leader in the biopharmaceutical industry, and a center for pharmaceutical production and distribution.

Pharmaceutical Executive
Features

April 01, 2013

List pricing strategies that diverge from these approaches without "hitting the cliff".

Pharmaceutical Executive

The European Union's attempt to update its transparency rules sparks new debate.

Pharmaceutical Executive

The slow evolution toward a state of grace in tracking ROI for digital promotion.

Pharmaceutical Executive

S

Pharmaceutical Executive

Improving the quality of clinical trials is a major strategic activity for Big Pharma, one where efficient management of a demanding set of regulatory requirements can have a positive impact on the bottom line.

Pharmaceutical Executive
Features

April 01, 2013

Pharm Exec's annual look at the trends and best practices in biopharm licensing and M&A for the year ahead.

Features

April 01, 2013

This year's HBA Woman of the Year is Merck's Bridgette Heller of Merck Consumer Care.

Pharmaceutical Executive

Take a page from the consumer marketing playbook and promote a product's advantage and why it should matter to the customer.

Pharmaceutical Executive
From the Editor

April 01, 2013

The conversation thread that binds this month's Pharm Exec is building communities-when the harsh economics of market change suddenly discounts the familiar, then the best way to move up is to reach out.

Pharmaceutical Executive
Column

April 01, 2013

Do Big Pharma dollars make physicians lousy caregivers?

Pharmaceutical Executive
Column

April 01, 2013

There seems no end to demands for data on clinical research, conflicts of interest, company payments, and drug prices.